Purchases and Sales Made in Q4 2024 in Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE) during Q4 2024. The information is specifically focused on institutions that hold shares of FATE THERAPEUTICS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
10.5K+ 30.59% |
$16.9K - $35.2K
|
44.9K
$57K
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
5.43KNew |
$8.74K - $18.2K
|
5.43K
$6.9K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-16- 0.09% |
$25.8 - $53.6
|
17.1K
$21.8K
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-135- 17.74% |
$217 - $452
|
626
$795
|
|
Jan 21, 2025
Q4 2024
|
Castleview Partners, LLC
Dallas, TX |
SELL
|
- |
-1.55K- 7.43% |
$2.49K - $5.18K
|
19.3K
$24.5K
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-2.06M- 84.7% |
$3.32M - $6.91M
|
373K
$473K
|